These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1492230)

  • 21. Acute myelomonocytic leukemia after treatment with chronic oral etoposide: are MLL and LTG9 genes targets for etoposide?
    Goto H; Shimazaki C; Tatsumi T; Yamagata N; Inaba T; Fujita N; Moriguchi T; Yamamoto K; Seto M; Ueda R
    Int J Hematol; 1994 Aug; 60(2):145-9. PubMed ID: 7948964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia.
    Shaklai S; Bairey O; Blickstein D; Prokocimer M; Hadar H; Lahav M; Sulkes J; Shaklai M
    Cancer; 1996 Jun; 77(11):2313-7. PubMed ID: 8635101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamic modeling of prolonged administration of etoposide.
    Minami H; Ratain MJ; Ando Y; Shimokata K
    Cancer Chemother Pharmacol; 1996; 39(1-2):61-6. PubMed ID: 8995500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adults.
    Le Deley MC; Vassal G; Taïbi A; Shamsaldin A; Leblanc T; Hartmann O
    Pediatr Blood Cancer; 2005 Jul; 45(1):25-31. PubMed ID: 15795880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two secondary leukemias among 15 children given oral etoposide.
    Schiavetti A; Varrasso G; Maurizi P; Castello MA
    Med Pediatr Oncol; 2001 Aug; 37(2):148-9. PubMed ID: 11496357
    [No Abstract]   [Full Text] [Related]  

  • 26. Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.
    Paredes J; Kahn JO; Tong WP; Feldstein ML; Lin S; Bennett JM; Metroka CE; Ratner L; Krown SE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):138-44. PubMed ID: 7749790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Report of a case with secondary acute promyelocytic leukemia after therapy for hemophagocytic lymphohistiocytosis and review of literature].
    Su Y; Zhou X; Zhang L; Zhang R
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):938-42. PubMed ID: 24495767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.
    Winick NJ; McKenna RW; Shuster JJ; Schneider NR; Borowitz MJ; Bowman WP; Jacaruso D; Kamen BA; Buchanan GR
    J Clin Oncol; 1993 Feb; 11(2):209-17. PubMed ID: 8426196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Secondary leukemia after etoposide treatment involved MLL gene rearrangement].
    Iida H; Taji H; Iida M; Suzuki R; Sugihara T; Minami S; Kodera Y; Yamamoto K; Seto M; Ueda R
    Rinsho Ketsueki; 1994 Jun; 35(6):569-75. PubMed ID: 8078192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique.
    Le Deley MC; Leblanc T; Shamsaldin A; Raquin MA; Lacour B; Sommelet D; Chompret A; Cayuela JM; Bayle C; Bernheim A; de Vathaire F; Vassal G; Hill C;
    J Clin Oncol; 2003 Mar; 21(6):1074-81. PubMed ID: 12637473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial.
    Bernstein SH; Fay JP; Christiansen NP; Pinero L; Shah D; Stephan M; Herzig GP
    Clin Cancer Res; 1997 Sep; 3(9):1519-26. PubMed ID: 9815838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
    RamaChandran S; Ariffin H
    Pediatr Blood Cancer; 2009 Sep; 53(3):488-90. PubMed ID: 19434733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of etoposide for carcinoma of the prostate.
    Walther PJ; Williams SD; Troner M; Greco FA; Birch R; Einhorn LH
    Cancer Treat Rep; 1986 Jun; 70(6):771-2. PubMed ID: 3524825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer.
    Zucchetti M; Pagani O; Torri V; Sessa C; D'Incalci M; De Fusco M; de Jong J; Gentili D; Martinelli G; Tinazzi A
    Clin Cancer Res; 1995 Dec; 1(12):1517-24. PubMed ID: 9815952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary leukaemia after epipodophyllotoxins.
    Hawkins MM
    Lancet; 1991 Nov; 338(8779):1408. PubMed ID: 1682778
    [No Abstract]   [Full Text] [Related]  

  • 36. Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Kitazawa J; Ito E; Arai K; Yokoyama M; Fukayama M; Imashuku S
    Med Pediatr Oncol; 2001 Aug; 37(2):153-4. PubMed ID: 11496359
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer.
    Miller AA; Tolley EA; Niell HB; Griffin JP; Mauer AM
    J Clin Oncol; 1993 Jun; 11(6):1179-88. PubMed ID: 8388920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of testicular cancer and the development of secondary malignancies.
    Bokemeyer C; Schmoll HJ
    J Clin Oncol; 1995 Jan; 13(1):283-92. PubMed ID: 7799032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I and pharmacologic study of 7- and 21-day continuous etoposide infusion in patients with advanced cancer.
    Robert F; Chen S; Miller AA; Lee BC; Molthrop DC; Wheeler RH
    Cancer Chemother Pharmacol; 1996; 38(5):459-65. PubMed ID: 8765440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia.
    Todisco E; Testi AM; Avvisati G; Moleti ML; Cedrone M; Cimino G; Mancini F; Amadori S; Mandelli F
    Leukemia; 1995 Sep; 9(9):1583-5. PubMed ID: 7658728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.